FeNO non-suppression identifies corticosteroid-resistant type-2 signaling in severe asthma

Míreanna comhchosúla

• FeNO non-suppression identifies corticosteroid-resistant type-2 signaling in severe asthma
  de réir: Couillard, S, et al.
  Foilsithe / Cruthaithe: (2021)
• Mechanisms of FeNO non-suppression in severe asthma: analysis of sputum type 2 cytokines and chemokines
  de réir: Couillard, S, et al.
  Foilsithe / Cruthaithe: (2020)
• Longitudinal changes in sputum and blood inflammatory mediators during FeNO suppression testing
  de réir: Couillard, S, et al.
  Foilsithe / Cruthaithe: (2022)
• Remotely monitored therapy and nitric oxide suppression identifies nonadherence in severe asthma
  de réir: Heaney, LG, et al.
  Foilsithe / Cruthaithe: (2018)
• Airway remodelling rather than cellular infiltration characterises both type2 cytokine biomarker-high and -low severe asthma
  de réir: Khalfaoui, L, et al.
  Foilsithe / Cruthaithe: (2022)